These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29977893)

  • 21. Manufacturing and banking of mesenchymal stem cells.
    Thirumala S; Goebel WS; Woods EJ
    Expert Opin Biol Ther; 2013 May; 13(5):673-91. PubMed ID: 23339745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogen reduction through additive-free short-wave UV light irradiation retains the optimal efficacy of human platelet lysate for the expansion of human bone marrow mesenchymal stem cells.
    Viau S; Chabrand L; Eap S; Lorant J; Rouger K; Goudaliez F; Sumian C; Delorme B
    PLoS One; 2017; 12(8):e0181406. PubMed ID: 28763452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages.
    Kim HJ; Park JS
    Dev Reprod; 2017 Mar; 21(1):1-10. PubMed ID: 28484739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor Variability in Growth Kinetics of Healthy hMSCs Using Manual Processing: Considerations for Manufacture of Cell Therapies.
    Detela G; Bain OW; Kim HW; Williams DJ; Mason C; Mathur A; Wall IB
    Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 29334181
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxygen Tension Regulates Human Mesenchymal Stem Cell Paracrine Functions.
    Paquet J; Deschepper M; Moya A; Logeart-Avramoglou D; Boisson-Vidal C; Petite H
    Stem Cells Transl Med; 2015 Jul; 4(7):809-21. PubMed ID: 25979862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools.
    Díez JM; Bauman E; Gajardo R; Jorquera JI
    Stem Cell Res Ther; 2015 Mar; 6(1):28. PubMed ID: 25889980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large-scale production of human mesenchymal stem cells for clinical applications.
    Jung S; Panchalingam KM; Wuerth RD; Rosenberg L; Behie LA
    Biotechnol Appl Biochem; 2012; 59(2):106-20. PubMed ID: 23586791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The translation of cell-based therapies: clinical landscape and manufacturing challenges.
    Heathman TR; Nienow AW; McCall MJ; Coopman K; Kara B; Hewitt CJ
    Regen Med; 2015; 10(1):49-64. PubMed ID: 25562352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency.
    Robb KP; Fitzgerald JC; Barry F; Viswanathan S
    Cytotherapy; 2019 Mar; 21(3):289-306. PubMed ID: 30528726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human resource development contributes to the creation of outstanding regenerative medicine products.
    Nishigaki F; Ezoe S; Kitajima H; Hata K;
    Regen Ther; 2017 Dec; 7():17-23. PubMed ID: 30271848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bringing Safe and Standardized Cell Therapies to Industrialized Processing for Burns and Wounds.
    Laurent A; Lin P; Scaletta C; Hirt-Burri N; Michetti M; de Buys Roessingh AS; Raffoul W; She BR; Applegate LA
    Front Bioeng Biotechnol; 2020; 8():581. PubMed ID: 32637400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic regulation of mesenchymal stem cell in expansion and therapeutic application.
    Liu Y; Ma T
    Biotechnol Prog; 2015; 31(2):468-81. PubMed ID: 25504836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Addressing the Manufacturing Challenges of Cell-Based Therapies.
    de Almeida Fuzeta M; de Matos Branco AD; Fernandes-Platzgummer A; da Silva CL; Cabral JMS
    Adv Biochem Eng Biotechnol; 2020; 171():225-278. PubMed ID: 31844924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine.
    Vizoso FJ; Eiro N; Cid S; Schneider J; Perez-Fernandez R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28841158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures.
    Cohn Yakubovich D; Sheyn D; Bez M; Schary Y; Yalon E; Sirhan A; Amira M; Yaya A; De Mel S; Da X; Ben-David S; Tawackoli W; Ley EJ; Gazit D; Gazit Z; Pelled G
    Stem Cell Res Ther; 2017 Mar; 8(1):51. PubMed ID: 28279202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety Profile of Good Manufacturing Practice Manufactured Interferon γ-Primed Mesenchymal Stem/Stromal Cells for Clinical Trials.
    Guess AJ; Daneault B; Wang R; Bradbury H; La Perle KMD; Fitch J; Hedrick SL; Hamelberg E; Astbury C; White P; Overolt K; Rangarajan H; Abu-Arja R; Devine SM; Otsuru S; Dominici M; O'Donnell L; Horwitz EM
    Stem Cells Transl Med; 2017 Oct; 6(10):1868-1879. PubMed ID: 28887912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Industry-Driven Roadmap for Manufacturing in Regenerative Medicine.
    Hunsberger JG; Shupe T; Atala A
    Stem Cells Transl Med; 2018 Aug; 7(8):564-568. PubMed ID: 30009571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
    Wuchter P; Bieback K; Schrezenmeier H; Bornhäuser M; Müller LP; Bönig H; Wagner W; Meisel R; Pavel P; Tonn T; Lang P; Müller I; Renner M; Malcherek G; Saffrich R; Buss EC; Horn P; Rojewski M; Schmitt A; Ho AD; Sanzenbacher R; Schmitt M
    Cytotherapy; 2015 Feb; 17(2):128-39. PubMed ID: 24856898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.
    Hare JM; DiFede DL; Rieger AC; Florea V; Landin AM; El-Khorazaty J; Khan A; Mushtaq M; Lowery MH; Byrnes JJ; Hendel RC; Cohen MG; Alfonso CE; Valasaki K; Pujol MV; Golpanian S; Ghersin E; Fishman JE; Pattany P; Gomes SA; Delgado C; Miki R; Abuzeid F; Vidro-Casiano M; Premer C; Medina A; Porras V; Hatzistergos KE; Anderson E; Mendizabal A; Mitrani R; Heldman AW
    J Am Coll Cardiol; 2017 Feb; 69(5):526-537. PubMed ID: 27856208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.